Legal Notice
Please click the 'ACCEPT' button at the bottom of this page if the following terms and conditions are acceptable. We will remember your selection for 30 days.

MATERIALS ON THIS WEBSITE ARE MADE AVAILABLE BY CRYSTAL AMBER FUND LIMITED FOR INFORMATION PURPOSES ONLY.

THESE MATERIALS ARE NOT DIRECTED AT, NOR ARE THEY INTENDED FOR USE BY, PERSONS LOCATED OR RESIDENT IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN.

Please read the disclaimers below carefully, as by using the Crystal Amber Fund Limited website you will be taken to have agreed to be bound by them.

Please note that the disclaimers set out below may be altered or updated. You should read them in full each time you visit this website.

The information on this website may change from time to time and this website may not be kept up to date. Neither Crystal Amber Fund Limited, Global Fund Management Services Limited nor Tarncourt Asset Management Limited shall be liable for any out of date information.

Any person viewing this website certifies that: (i) they are not located in the United States and are not a U.S. person (as such terms are defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")) and (ii) they are not located in Canada, Australia, South Africa or Japan.

For the purposes of clarification, the documents and information presented on this website are solely for information purposes and nothing contained in these website pages constitutes or forms part of any offer, or any solicitation of any offer, or any inducement, advertisement or promotion, in relation to: (i) any securities, investments, products or services in any jurisdiction or (ii) any prospective contract with Crystal Amber Fund Limited or any other company. The information provided and the fact of its distribution shall not form the basis of, or be relied upon in connection with, any contract, commitment or investment decision. The information contained within this website does not constitute financial, professional or investment advice. If you are in any doubt you should consult your own independent financial adviser, stockbroker, solicitor, accountant or other professional adviser.

Past performance is no guide to the future. The value of investments and the income from them may go down as well as up and investors may not get back the full amount they originally invested. The information herein has been obtained from sources believed to be reliable but no representation or warranty is given or may be implied that they are accurate or complete.

Viewing information on this site or otherwise receiving information in relation to Crystal Amber Fund Limited may not be lawful in certain jurisdictions. In other jurisdictions only certain categories of person may be allowed to view this information. A person who wishes to view this site must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so. If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials please exit the website.

Access to electronic versions of the various materials presented at this website is being made available in good faith and for information purposes only. Any person seeking access to this site represents and warrants to Crystal Amber Fund Limited that they are doing so for information purposes only. Making press announcements and other information available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in Crystal Amber Fund Limited anywhere in the world. Further, it does not constitute a recommendation by Crystal Amber Fund Limited, Global Fund Management Services Limited, Tarncourt Asset Management Limited or any other person to sell or buy securities in Crystal Amber Fund Limited or otherwise. These materials do not constitute an invitation or advice to underwrite, subscribe for, or otherwise acquire or dispose of, securities in Crystal Amber Fund Limited.

Any securities or related instruments of the Crystal Amber Fund Limited discussed or referred to in the materials on this website have not been, and will not be, registered under the Securities Act, or under the securities legislation of any state of the United States. Accordingly, any such securities may not, directly or indirectly, be offered, sold pledged or otherwise transferred, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as such terms are defined in Regulation S under the Securities Act) unless the securities are registered under the Securities Act and the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act") or exemptions from the registration requirements of the Securities Act and the Investment Company Act are available. Any securities or related instruments of the Crystal Amber Fund Limited discussed or referred to in the materials on this website have not been recommended by any U.S. federal or state securities commission or regulatory authority nor have any such authorities confirmed the accuracy or adequacy of the various materials presented on this website. Any representation to the contrary is a criminal offence in the United States. Hedging transactions involving such securities may not be conducted unless in compliance with the Securities Act.

The Fund is not incorporated in the UK and the rights of shareholders may be different from the rights of shareholders in a UK incorporated company. 
AcceptDecline
Please note: If you are unable to proceed after clicking the 'ACCEPT' button above, you will need to ensure cookies are enabled on the browser you are using. Crystal Amber will not store or use any personal information we obtain from you, the use of a cookie is used to ensure your acceptance of this disclaimer.
News
31st December 2025Total Voting RightsView Document
29th December 2025Transaction in Own Shares and Total Voting RightsView Document
23rd December 2025Transaction in Own Shares and Total Voting RightsView Document
22nd December 2025Transaction in Own Shares and Total Voting RightsView Document
19th December 2025Transaction in Own Shares and Total Voting RightsView Document
18th December 2025Transaction in Own Shares and Total Voting RightsView Document
17th December 2025Transaction in Own Shares and Total Voting RightsView Document
17th December 2025Monthly Net Asset ValueView Document
16th December 2025Transaction in Own Shares and Total Voting RightsView Document
15th December 2025Transaction in Own Shares and Total Voting RightsView Document
15th December 2025Transaction in Own Shares and Total Voting RightsView Document
11th December 2025Transaction in Own Shares and Total Voting RightsView Document
11th December 2025Director/PDMR ShareholdingView Document
9th December 2025Transaction in Own Shares and Total Voting RightsView Document
8th December 2025Transaction in Own Shares and Total Voting RightsView Document
5th December 2025Transaction in Own Shares and Total Voting RightsView Document
4th December 2025Transaction in Own Shares and Total Voting RightsView Document
3rd December 2025Share Buyback ProgrammeView Document
2nd December 2025Result of AGMView Document
1st December 2025Transaction in Own Shares and Total Voting RightsView Document
24th November 2025Transaction in Own Shares and Total Voting RightsView Document
21st November 2025Transaction in Own Shares and Total Voting RightsView Document
20th November 2025Share Buyback ProgrammeView Document
20th November 2025Monthly Net Asset ValueView Document
18th November 2025Director/PDMR ShareholdingView Document
17th November 2025Transaction in Own Shares and Total Voting RightsView Document
17th November 2025Holding(s) in CompanyView Document
14th November 2025Transaction in Own Shares and Total Voting RightsView Document
14th November 2025Proposed change of strategy and investment managerView Document
13th November 2025Transaction in Own Shares and Total Voting RightsView Document
6th November 2025Notice of AGMView Document
31st October 2025Total Voting RightsView Document
27th October 2025Transaction in Own Shares and Total Voting RightsView Document
24th October 2025Monthly Net Asset ValueView Document
24th October 2025Monthly Net Asset ValueView Document
24th October 2025Monthly Net Asset ValueView Document
24th October 2025Monthly Net Asset ValueView Document
20th October 2025Transaction in Own Shares and Total Voting RightsView Document
20th October 2025Share Buyback ProgrammeView Document
17th October 2025Final ResultsView Document
16th October 2025Investor Presentation by Morphic Medical IncView Document
7th October 2025Investor Presentation by Morphic Medical IncView Document
30th September 2025Transaction in Own Shares and Total Voting RightsView Document
29th September 2025Transaction in Own Shares and Total Voting RightsView Document
25th September 2025Transaction in Own Shares and Total Voting RightsView Document
22nd September 2025Transaction in Own Shares and Total Voting RightsView Document
17th September 2025Transaction in Own Shares and Total Voting RightsView Document
15th September 2025Morphic Medical Inc. appoints new CFOView Document
10th September 2025Transaction in Own Shares and Total Voting RightsView Document
4th September 2025Transaction in Own Shares and Total Voting RightsView Document
2nd September 2025Transaction in Own Shares and Total Voting RightsView Document
29th August 2025Total Voting RightsView Document
27th August 2025MMI's RESET achieves UK regulator registrationView Document
26th August 2025Transaction in Own Shares and Total Voting RightsView Document
21st August 2025Transaction in Own Shares and Total Voting RightsView Document
19th August 2025Transaction in Own Shares and Total Voting RightsView Document
11th August 2025Transaction in Own Shares and Total Voting RightsView Document
6th August 2025Transaction in Own Shares and Total Voting RightsView Document
5th August 2025Transaction in Own Shares and Total Voting RightsView Document
5th August 2025Transaction in Own Shares and Total Voting RightsView Document
5th August 2025Morphic Medical Inc. appoints new Chief ExecutiveView Document
4th August 2025Share Buyback ProgrammeView Document
31st July 2025Total Voting RightsView Document
24th July 2025Transaction in Own Shares and Total Voting RightsView Document
24th July 2025Holding(s) in CompanyView Document
24th July 2025Transaction in Own Shares and Total Voting RightsView Document
24th July 2025Director/PDMR ShareholdingView Document
22nd July 2025Transaction in Own Shares and Total Voting RightsView Document
18th July 2025Fund updateView Document
9th July 2025Transaction in Own Shares and Total Voting RightsView Document
8th July 2025Holding(s) in CompanyView Document
7th July 2025Holding(s) in CompanyView Document
3rd July 2025Morphic Medical Inc obtains regulatory approvalView Document
2nd July 2025Transaction in Own Shares and Total Voting RightsView Document
1st July 2025Share Buyback ProgrammeView Document
30th June 2025Transaction in Own Shares and Total Voting RightsView Document
27th June 2025Transaction in Own Shares and Total Voting RightsView Document
26th June 2025Transaction in Own Shares and Total Voting RightsView Document
25th June 2025Transaction in Own Shares and Total Voting RightsView Document
24th June 2025Transaction in Own Shares and Total Voting RightsView Document
23rd June 2025Transaction in Own Shares and Total Voting RightsView Document
20th June 2025Monthly Net Asset ValueView Document
20th June 2025Transaction in Own Shares and Total Voting RightsView Document
18th June 2025Transaction in Own Shares and Total Voting RightsView Document
18th June 2025Holding(s) in CompanyView Document
17th June 2025Transaction in Own Shares and Total Voting RightsView Document
16th June 2025Transaction in Own Shares and Total Voting RightsView Document
16th June 20252024 AGM Voting Update StatementView Document
13th June 2025Transaction in Own Shares and Total Voting RightsView Document
12th June 2025Transaction in Own Shares and Total Voting RightsView Document
9th June 2025Transaction in Own Shares and Total Voting RightsView Document
6th June 2025Transaction in Own Shares and Total Voting RightsView Document
4th June 2025Transaction in Own Shares and Total Voting RightsView Document
2nd June 2025Transaction in Own Shares and Total Voting RightsView Document
30th May 2025Transaction in Own Shares and Total Voting RightsView Document
29th May 2025Transaction in Own Shares and Total Voting RightsView Document
27th May 2025Transaction in Own Shares and Total Voting RightsView Document
23rd May 2025Transaction in Own Shares and Total Voting RightsView Document
23rd May 2025Transaction in Own Shares and Total Voting RightsView Document
21st May 2025Transaction in Own Shares and Total Voting RightsView Document
20th May 2025Transaction in Own Shares and Total Voting RightsView Document
19th May 2025Transaction in Own Shares and Total Voting RightsView Document
16th May 2025Transaction in Own Shares and Total Voting RightsView Document
15th May 2025Monthly Net Asset ValueView Document
15th May 2025Transaction in Own Shares and Total Voting RightsView Document
6th May 2025Holding(s) in CompanyView Document
1st May 2025Transaction in Own Shares and Total Voting RightsView Document
30th April 2025Total Voting RightsView Document
25th April 2025Transaction in Own Shares and Total Voting RightsView Document
23rd April 2025Holding(s) in CompanyView Document
23rd April 2025Holding(s) in CompanyView Document
22nd April 2025Transaction in Own Shares and Total Voting RightsView Document
22nd April 2025Holding(s) in CompanyView Document
22nd April 2025Transaction in Own Shares and Total Voting RightsView Document
15th April 2025Form 8.3 - De La Rue plcView Document
14th April 2025Monthly Net Asset ValueView Document
10th April 2025Form 8.3 - De La Rue plcView Document
9th April 2025Form 8.3 - ReplacementView Document
9th April 2025Form 8.3 - De La Rue plcView Document
8th April 2025Transaction in Own Shares and Total Voting RightsView Document
8th April 2025Form 8.3 - De La Rue plcView Document
7th April 2025Form 8.3 - De La Rue plcView Document
7th April 2025Transaction in Own Shares and Total Voting RightsView Document
4th April 2025Form 8.3 - ReplacementView Document
4th April 2025Form 8.3 - De La Rue plcView Document
1st April 2025Total Voting RightsView Document
31st March 2025Monthly Net Asset ValueView Document
27th March 2025Transaction in Own Shares and Total Voting RightsView Document
25th March 2025Director/PDMR ShareholdingView Document
24th March 2025Share Buyback ProgrammeView Document
21st March 2025Half-year ReportView Document
14th March 2025Cancellation of treasury sharesView Document
6th March 2025Form 8.3 - De La Rue plcView Document
28th February 2025Total Voting RightsView Document
24th February 2025Holding(s) in CompanyView Document
24th February 2025Transaction in Own Shares and Total Voting RightsView Document
21st February 2025Transaction in Own Shares and Total Voting RightsView Document
21st February 2025Holding(s) in CompanyView Document
20th February 2025Holding(s) in CompanyView Document
20th February 2025Update on Morphic Medical Inc.View Document
19th February 2025Transaction in Own Shares and Total Voting RightsView Document
19th February 2025Director/PDMR ShareholdingView Document
19th February 2025Form 8.3 - De La Rue plcView Document
18th February 2025Monthly Net Asset ValueView Document
18th February 2025Transaction in Own Shares and Total Voting RightsView Document
17th February 2025Transaction in Own Shares and Total Voting RightsView Document
13th February 2025Transaction in Own Shares and Total Voting RightsView Document
13th February 2025Transaction in Own Shares and Total Voting RightsView Document
12th February 2025Transaction in Own Shares and Total Voting RightsView Document
10th February 2025Form 8.3 - De La Rue plcView Document
10th February 2025Transaction in Own Shares and Total Voting RightsView Document
10th February 2025Transaction in Own Shares and Total Voting RightsView Document
7th February 2025Form 8.3 - De La Rue plcView Document
6th February 2025Transaction in Own Shares and Total Voting RightsView Document
6th February 2025Holding(s) in CompanyView Document
5th February 2025Transaction in Own Shares and Total Voting RightsView Document
5th February 2025Form 8.3 - ReplacementView Document
4th February 2025Transaction in Own Shares and Total Voting RightsView Document
4th February 2025Form 8.3 - De La Rue plcView Document
3rd February 2025Transaction in Own Shares and Total Voting RightsView Document
31st January 2025Total Voting RightsView Document
31st January 2025Holding(s) in CompanyView Document
30th January 2025Form 8.3 - De La Rue plcView Document
30th January 2025Transaction in Own Shares and Total Voting RightsView Document
30th January 2025Form 8.3 - De La Rue plcView Document
30th January 2025Transaction in Own Shares and Total Voting RightsView Document
29th January 2025Share Buyback ProgrammeView Document
28th January 2025Transaction in Own Shares and Total Voting RightsView Document
28th January 2025Form 8.3 - De La Rue plcView Document
28th January 2025Transaction in Own Shares and TVR - ReplacementView Document
28th January 2025Transaction in Own Shares and TVR - ReplacementView Document
28th January 2025Transaction in Own Shares and Total Voting RightsView Document
24th January 2025Transaction in Own Shares and Total Voting RightsView Document
23rd January 2025Monthly Net Asset ValueView Document
21st January 2025Form 8.3 - De La Rue plcView Document
20th January 2025Transaction in Own Shares and Total Voting RightsView Document
20th January 2025Form 8.3 - De La Rue plcView Document
20th January 2025Transaction in Own Shares and Total Voting RightsView Document
17th January 2025Form 8.3 - De La Rue plcView Document
16th January 2025Form 8.3 - De La Rue plcView Document
15th January 2025Transaction in Own Shares and Total Voting RightsView Document
13th January 2025Conversion of loan notes in Morphic - ReplacementView Document
13th January 2025Conversion of loan notes in Morphic Medical Inc.View Document
9th January 2025Transaction in Own Shares and Total Voting RightsView Document
8th January 2025Form 8.3 - De La Rue plcView Document